» Articles » PMID: 29804531

Intestinal Crosstalk Between Microbiota and Serotonin and Its Impact on Gut Motility

Overview
Date 2018 May 29
PMID 29804531
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The gastrointestinal tract harbours a diverse bacterial community that contributes to health and disease. A number of studies have demonstrated that the gut microbiota plays a critical role in the metabolism of serotonin.

Methods: Microbial-derived metabolites, such as bile acids and short-chain fatty acids, are reported to affect the production of serotonin which, in turn, directly or indirectly regulates gut motility. Enterochromaffin cells are important specialized endocrine cells found in the intestine, which is the major location of serotonin biosynthesis. The relationship between microbiota and gut motility are studied depended on microbial-derived metabolites and serotonin.

Results And Conclusion: Both bile acids and short-chain fatty acids can modulate serotonin metabolism in hosts by affecting key intermediates of the serotonin pathway. Thus, gut motility may be regulated through microbial modifications of host serotonin biosynthesis, which continues to be evaluated as a target for functional gastrointestinal disorders.

Citing Articles

The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering.

Deng N, Xie S, Liu Q, Peng H, Fang L, Shen J Front Cell Infect Microbiol. 2025; 15:1549617.

PMID: 40051709 PMC: 11882872. DOI: 10.3389/fcimb.2025.1549617.


Microbial melatonin metabolism in the human intestine as a therapeutic target for dysbiosis and rhythm disorders.

Zimmermann P, Kurth S, Pugin B, Bokulich N NPJ Biofilms Microbiomes. 2024; 10(1):139.

PMID: 39604427 PMC: 11603051. DOI: 10.1038/s41522-024-00605-6.


A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease.

Ayyanar M, Vijayan M Geroscience. 2024; 47(1):339-385.

PMID: 39562408 PMC: 11872870. DOI: 10.1007/s11357-024-01432-5.


Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia.

Ferraz-Bannitz R, Ozturk B, Cummings C, Efthymiou V, Casanova Querol P, Poulos L J Clin Invest. 2024; 134(21).

PMID: 39264731 PMC: 11527454. DOI: 10.1172/JCI180157.


Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare.

Mohr A, Ortega-Santos C, Whisner C, Klein-Seetharaman J, Jasbi P Biomedicines. 2024; 12(7).

PMID: 39062068 PMC: 11274472. DOI: 10.3390/biomedicines12071496.